Benzos and the prescription that became a habit

There is a particular kind of discomfort in realising that a medication your doctor prescribed, that you have taken as directed, has made you physically dependent on it. It doesn't fit the cultural script of drug dependence — there was no misuse, no escalation beyond what was prescribed, no loss of control. And yet the experience of attempting to stop, or even reduce, reveals a withdrawal that confirms something has changed in your physiology without your having chosen it.

This is the situation many Australians are in with benzodiazepines. It is common, it is not the result of moral failure, and it is worth understanding clearly.

What benzodiazepines are and what they do

Benzodiazepines — diazepam (Valium), alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), temazepam, oxazepam, and others — are a class of central nervous system depressants that work by enhancing the effect of GABA, the brain's main inhibitory neurotransmitter. They reduce neural activity. They produce calm, muscle relaxation, reduced anxiety, and sleep.

They are effective, in the short term, for all of these purposes. The problem is that the brain adapts to them — and this adaptation happens faster than most prescribing conversations prepare people for.

Australian Prescriber notes that physical dependence can develop within weeks of regular use. The standard guidance from the Royal Australian College of General Practitioners is that benzodiazepines should generally not be prescribed for more than 2–4 weeks for this reason. In practice, many people have been on them for months or years — sometimes because acute situations became chronic ones, sometimes because the prescribing context changed, sometimes simply because the repeat prescription continued.

What dependence feels like from the inside

Physical dependence on benzodiazepines is not the same as what is colloquially called addiction. Addiction involves compulsive use despite harm, loss of control over use, and craving. Physical dependence is a physiological adaptation where the body has come to rely on the drug to maintain baseline function.

The practical difference matters: many people who are physically dependent on benzodiazepines do not experience strong cravings, do not escalate their dose, and use exactly as prescribed. What they do experience is:

Tolerance, where the same dose produces less effect than it originally did. The tablet that once reliably helped with sleep does so less reliably now. The dose that previously eliminated anxiety reduces it but doesn't resolve it. Tolerance develops at different rates in different people, but it is the norm rather than the exception with regular benzodiazepine use.

Interdose withdrawal, which is particularly common with shorter-acting benzodiazepines like alprazolam. This is the phenomenon where anxiety or physical symptoms — tremor, sweating, rapid heart rate — emerge in the hours between doses, before the next dose is due. Many people taking benzodiazepines for anxiety experience interdose withdrawal as the return or worsening of their original anxiety, without recognising that it is partly a withdrawal phenomenon. The medication prescribed for anxiety is generating some of the anxiety it is then used to treat.

Withdrawal symptoms when stopping that are more significant than the original presenting condition. This is the most disorienting aspect for many people: attempting to stop a medication they were told was safe, at prescribed doses, and experiencing severe anxiety, insomnia, physical symptoms, and in serious cases seizure risk. The Ashton Manual, developed by Professor Heather Ashton at Newcastle University following decades of clinical work with benzodiazepine-dependent patients, remains the most comprehensive patient-oriented guide to benzodiazepine withdrawal and tapering.

The specific challenge of sleep benzos

Temazepam and nitrazepam are frequently prescribed for sleep. The initial effectiveness is real — benzodiazepines do help people fall asleep and stay asleep in the short term. The longer-term picture is more complicated.

As with alcohol, benzodiazepines suppress REM sleep. Over weeks and months of use, sleep architecture deteriorates: sleep may be chemically maintained but is less restorative. The insomnia that eventually emerges when the medication is reduced or stopped is often more severe than the insomnia that prompted prescribing in the first place — a rebound insomnia driven by CNS adaptation rather than a return of the original problem.

This creates a situation where the medication initially prescribed for insomnia is now both sustaining a degree of sleep and preventing recovery of normal sleep function. Understanding this dynamic — that the medication may be participating in the problem it was prescribed to address — is important for making informed decisions about how to proceed.

What the options look like

If you are taking benzodiazepines as prescribed and concerned about dependence, or finding that stopping or reducing is more difficult than expected, the most important first step is an honest conversation with your GP. Abrupt cessation of benzodiazepines carries genuine medical risks including seizures, particularly with high doses or long-term use. This is not a situation to manage alone.

The standard evidence-based approach to benzodiazepine dependence is a slow, supported taper — reducing the dose gradually over weeks or months in a way that allows the CNS to readapt incrementally. The RACGP guidance on prescribing drugs of dependence provides a framework for this. Cognitive behavioural therapy for insomnia (CBT-I) has strong evidence as an alternative to ongoing benzodiazepine use for sleep problems and can support the tapering process.

Many people find that tracking their mood, sleep, and anxiety alongside medication changes gives them genuinely useful data during a taper — rather than relying on moment-to-moment subjective impression, they can see whether their functioning is actually stable or deteriorating on a longer trajectory.

If your GP is not comfortable managing a benzodiazepine taper or the dependence is complex, specialist referral to an addiction medicine physician or a hospital-based drug and alcohol service is appropriate. This is not crisis treatment — it is specialist support for a clinical situation that warrants it.

---

Tracking your mood, sleep, and substance use through a taper or change process gives you accurate data instead of impressions. ayodee is anonymous, no email required. ayodee.app.